首页|简化整体抗磷脂综合征评分在原发性抗磷脂抗体持续阳性患者中的临床价值

简化整体抗磷脂综合征评分在原发性抗磷脂抗体持续阳性患者中的临床价值

Clinical value of the adjusted global antiphospholipid syndrome score in patients with positive an-tiphospholipid antibodies

扫码查看
目的 评估简化整体抗磷脂综合征评分(aGAPSS)在抗磷脂抗体(aPL)持续阳性患者中的临床价值.方法 回顾性分析2012年5月至2022年8月就诊于北京大学第一医院风湿免疫科且aPL持续阳性患者的临床资料,合并其他结缔组织病的患者除外.收集人口统计学数据、传统心血管血栓危险因素、aPL谱、APS分类标准内和标准外临床表现等,根据风险指标计算所有患者的aGAPSS,通过秩和检验分析aGAPSS与临床表现的相关性.通过受试者工作特征(ROC)曲线评价aGAPSS对不同临床表现的诊断价值.结果 共纳入67例aPL持续阳性患者,包括15例aPL持续阳性但不满足APS分类标准和52例明确诊断原发性APS的患者,其中20例有血栓病史、36例有病态妊娠史、24例有APS分类标准外临床表现.与无血栓病史的患者相比,既往有任何血栓史或有动脉血栓史患者的aGAPSS评分显著更高[任何血栓史11.50(8.25,13.00)与 8.00(4.00,13.00),Z=2.33,P=0.020;动脉血栓史 11.00(9.00,14.00)与 8.00(4.00,13.00),H=6.21,P=0.043].有任何APS分类标准外临床表现患者的aGAPSS评分显著高于无相应临床表现的患者[13.00(8.25,13.00)与 8.00(4.00,11.00),Z=2.81,P=0.005],其中表现为血小板减少患者的 aGAPSS评分显著高于无血小板减少的患者[12.50(8.00,13.25)与8.00(4.00,13.00),Z=2.23,P=0.026].对育龄期女性进行亚组分析发现,aGAPSS评分在有无病态妊娠史的2组患者中差异无统计学意义.以血栓为终点事件,aGAPSS≥10分时的价值价值最高(灵敏度和特异度分别为65.0%和77.8%).结论 在原发性aPL持续阳性患者中,aGAPSS评分与血栓史及APS分类标准外临床表现,尤其是与血小板减少具有一定相关性.
Objective To evaluate the clinical value of the adjusted global antiphospholipid syndrome score(aGAPSS)in patients with persistent antiphospholipid antibodies(aPL).Methods The clinical data of patients who were continuously positive for aPL from May 2012 to August 2022 were retrospectively analyzed,except for patients complicated with connective tissue diseases.Demographic data,traditional cardiovascular thrombosis risk factors,aPL profile,and clinical manifestations included and not included in antiphospholipid syndrome(APS)were collected,and aGAPSS was calculated for all patients according to risk indicators and the correlation with clinical manifestation was analyzed through rank sum test.The diagnostic value of aGAPSS for different clinical manifestations was evaluated by the receiver operator characteristic(ROC)curve.Results A total of 67 patients with persistent aPL were enrolled,including 15 patients with persistent extra-criteria positive aPL but did not meet the APS classification criteria and 52 patients with a clear diagnosis of primary APS,of which 20 had a history of thrombosis,36 had a history of pregnancy morbidity,and 24 had extra-criteria clinical manifestations.Patients with history of any thrombosis or arterial thrombosis scored significantly higher than those with no history of thrombosis[any history of thrombosis 11.50(8.25,13.00)vs 8.00(4.00,13.00),Z=2.33,P=0.020;arterial thrombosis history 11.00(9.00,14.00)vs 8.00(4.00,13.00),H=6.21,P=0.043].The aGAPSS score of patients with extra-criteria clinical manifestations was significantly higher than that of patients without corresponding clinical manifestations[13.00(8.25,13.00)vs 8.00(4.00,11.00),Z=2.81,P=0.005],and the aGAPSS score of patients with thrombocytopenia was significantly higher than that of patients without thrombocytopenia[12.50(8.00,13.25)vs 8.00(4.00,13.00),Z=2.23,P=0.026].A subgroup analysis of pregnant women found no statistically significant difference in aGAPSS scores between groups with or without a history of pregnancy morbidity.With thrombosis as the endpoint event,aGAPSS had the highest diagnostic value at 10 points(sensitivity and specificity were 65.00%and 77.78%,respectively).Conclusion In patients with postivity aPL positivity,aGAPSS score is correlated with thrombosis history and extra-criteria clinical manifestations,especially thrombocytopenia.

Antibodies,antiphospholipidAntiphospholipid syndromeAdjusted global antiphospho-lipid syndrome score

谢晓旦、季兰岚、张卓莉

展开 >

北京大学第一医院风湿免疫科,北京 100034

抗体,抗磷脂 抗磷脂综合征 简化整体抗磷脂综合征评分

2024

中华风湿病学杂志
中华医学会

中华风湿病学杂志

CSTPCD
影响因子:0.651
ISSN:1007-7480
年,卷(期):2024.28(6)
  • 2